Company intelligence / Profile preview
Tiziana Life Sciences
Hamilton, Bermudatizianalifesciences.com ↗
- Ownership
- Public · TLSA
- Employees
- ~9
- Development stage
- Phase 2
01
Overview
Currently conducting Phase 2 clinical trials for intranasal Foralumab in non-active Secondary Progressive Multiple Sclerosis (na-SPMS) at multiple prestigious medical centers including Johns Hopkins University, Yale University, and Brigham and Women's Hospital. Phase 2 trial for Mild Alzheimer's Disease scheduled to begin in 1H 2025. Expanded Access Program for Moderate Alzheimer's Disease began dosing in December 2024. The company has received a grant from the ALS Association for Phase 2 clinical trial development.
- Therapeutic areas
- GastroenterologyEndocrinologyOncologyNeurologyInfectious Diseases
- Modalities
- Monoclonal antibodies (mAbs)ImmunotherapiesAlternative routes of administration (intranasal, oral, inhalation)
- Industry
- Biotech
02
Drug pipeline
7 assets6 more assets in the full pipeline.
Request access →03
Partnerships
Precision BioSciences (2021)FHI Clinical (2021)
04
Financials
- Market cap
- $62.1M
- Total revenue
- $0
- Enterprise value
- $58.6M
Beyond the preview
Go deeper on Tiziana Life Sciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tiziana Life Sciences.